Environmentally Persistent Pharmaceutical Pollutants

ICCM4 adopted environmentally persistent pharmaceutical pollutants as an emerging policy issue in the SAICM context, while recognizing that pharmaceuticals have major benefits for human health and animal welfare. In adopting the issue, ICCM4 agreed international cooperation is crucial to build awareness and promote action on the issue.

ICCM4 considered that information dissemination and awareness-raising on environmentally persistent pharmaceutical pollutants are particularly relevant and that improving the availability of and access to information on such chemicals is a priority. It also recognized the current knowledge gaps on exposure to and the effects of environmentally persistent pharmaceutical pollutants and decided to implement cooperative actions with the overall objective of increasing awareness and understanding among policymakers and other stakeholders.

The resolution invites Governments and other stakeholders to generate and share information to fill the identified knowledge gaps and requests all interested stakeholders and organizations to provide support, including expertise, financial and in-kind resources, on a voluntary basis, for cooperative action, including by participating in developing and making available relevant information and guidance.

Relevant participating organizations of the Inter-Organization Programme for the Sound Management of Chemicals will lead and facilitate cooperative action and are currently developing a plan of work on environmentally persistent pharmaceutical pollutants.

Environmentally Persistent Pharmaceuticals

Copyright 2021 by SAICM